Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer

L. Khan; D. Breen; L. Zhang; J. Balogh; G. Czarnota; J. Lee; M.N. Tsao; E.A. Barnes

doi:10.3747/co.21.1727

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Article

1 April 2014

Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer

and

University of Toronto, Toronto, ON, Canada

Author to whom correspondence should be addressed.

Curr. Oncol.2014, 21(2), 326-329;https://doi.org/10.3747/co.21.1727

Version Notes

Order Reprints

Abstract

Predictive factors of recurrence were examined in 448 non-melanoma skin cancers (72% basal cell carcinoma, 28% squamous cell carcinoma) treated with radiotherapy. The overall recurrence rate was 15.8% at a median follow-up of 18.4 months. In multivariate analysis, significant factors for recurrence were age (p = 0.0197), tumour size 2 cm or greater (p = 0.0095), immunosuppression (p = 0.0082), and treatment modality (p = 0.0009).

Keywords:

skin cancer; recurrence; radiotherapy

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Evidence-Based Guidelines for the Use of Tyrosine Kinase Inhibitors in Adults with Philadelphia Chromosome–Positive or Bcr-Abl–Positive Acute Lymphoblastic Leukemia: A Canadian Consensus

Screening for Distress in Patients with Cancer: Methodologic Considerations